Anti-NMDA receptor encephalitis physical examination: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Anti-NMDA receptor encephalitis}} {{CMG}} ==Overview== ==Physical Examination== ==References== {{Reflist|2}} Category:Needs content [[Category:Rheumatology]...") |
|||
| (5 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Anti-NMDA receptor encephalitis}} | {{Anti-NMDA receptor encephalitis}} | ||
{{CMG}} | {{CMG}} AE {{DMakkar}} | ||
==Overview== | ==Overview== | ||
The physical examination findings in Anti-NMDA encephalitis are non-specific. Patients may exhibit symptoms of widespread encephalopathy, altered states of consciousness, orofacial dysostosis, dyskinesis, dystonia, and autonomic storming. Neurological examination may reveal signs of diffuse cerebral dysfunction, including reflex abnormalities and mild ataxia. | |||
==Physical Examination== | ==Physical Examination== | ||
Common physical examination findings of Anti-NMDA encephalitis include: | |||
*Systemic and neurological symptoms lack specificity. The clinical examination does not reveal any indicators of anti-NMDAR encephalitis.Patients exhibit symptoms of widespread encephalopathy, suggesting neurologic impairment of subcortical, limbic, and frontostriatal circuitry. Some features of neurological disorders include | |||
**orofacial dysostosis, dyskinesis, choreoathetosis, dystonia, oculogyric crises, stiffness, pelvic thrusting and opisthotonic posture. | |||
*Multiple altered states of consciousness are possible. Infrequently, signs of elevated intracranial pressure may be observed in the aftermath of protracted status epilepticus. | |||
*In addition to mobility difficulties, a neurologic examination may reveal nonspecific symptoms of diffuse cerebral dysfunction, such as increased deep tendon reflexes, extensor plantar responses, and tone abnormalities. | |||
*Soft neurologic symptoms, including mild ataxia and difficulty with fine motor coordination, may also be present. | |||
**tachycardia and hypertension, are signs of autonomic storming in patients. | |||
==References== | ==References== | ||
| Line 12: | Line 23: | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
<ref name="pmid18851928">{{cite journal| author=Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M | display-authors=etal| title=Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. | journal=Lancet Neurol | year= 2008 | volume= 7 | issue= 12 | pages= 1091-8 | pmid=18851928 | doi=10.1016/S1474-4422(08)70224-2 | pmc=2607118 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18851928 }} </ref> | |||
<ref name="pmid23946310">{{cite journal| author=Titulaer MJ, McCracken L, Gabilondo I, Iizuka T, Kawachi I, Bataller L | display-authors=etal| title=Late-onset anti-NMDA receptor encephalitis. | journal=Neurology | year= 2013 | volume= 81 | issue= 12 | pages= 1058-63 | pmid=23946310 | doi=10.1212/WNL.0b013e3182a4a49c | pmc=3795591 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23946310 }} </ref> | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 12:01, 13 May 2023
|
Anti-NMDA receptor encephalitis Microchapters |
|
Differentiating Anti-NMDA receptor encephalitis from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anti-NMDA receptor encephalitis physical examination On the Web |
|
American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis physical examination |
|
Anti-NMDA receptor encephalitis physical examination in the news |
|
Blogs on Anti-NMDA receptor encephalitis physical examination |
|
Directions to Hospitals Treating Anti-NMDA receptor encephalitis |
|
Risk calculators and risk factors for Anti-NMDA receptor encephalitis physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] AE Dheeraj Makkar, M.D.[2]
Overview
The physical examination findings in Anti-NMDA encephalitis are non-specific. Patients may exhibit symptoms of widespread encephalopathy, altered states of consciousness, orofacial dysostosis, dyskinesis, dystonia, and autonomic storming. Neurological examination may reveal signs of diffuse cerebral dysfunction, including reflex abnormalities and mild ataxia.
Physical Examination
Common physical examination findings of Anti-NMDA encephalitis include:
- Systemic and neurological symptoms lack specificity. The clinical examination does not reveal any indicators of anti-NMDAR encephalitis.Patients exhibit symptoms of widespread encephalopathy, suggesting neurologic impairment of subcortical, limbic, and frontostriatal circuitry. Some features of neurological disorders include
- orofacial dysostosis, dyskinesis, choreoathetosis, dystonia, oculogyric crises, stiffness, pelvic thrusting and opisthotonic posture.
- Multiple altered states of consciousness are possible. Infrequently, signs of elevated intracranial pressure may be observed in the aftermath of protracted status epilepticus.
- In addition to mobility difficulties, a neurologic examination may reveal nonspecific symptoms of diffuse cerebral dysfunction, such as increased deep tendon reflexes, extensor plantar responses, and tone abnormalities.
- Soft neurologic symptoms, including mild ataxia and difficulty with fine motor coordination, may also be present.
- tachycardia and hypertension, are signs of autonomic storming in patients.
References
- ↑ Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M; et al. (2008). "Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies". Lancet Neurol. 7 (12): 1091–8. doi:10.1016/S1474-4422(08)70224-2. PMC 2607118. PMID 18851928.
- ↑ Titulaer MJ, McCracken L, Gabilondo I, Iizuka T, Kawachi I, Bataller L; et al. (2013). "Late-onset anti-NMDA receptor encephalitis". Neurology. 81 (12): 1058–63. doi:10.1212/WNL.0b013e3182a4a49c. PMC 3795591. PMID 23946310.